Skip to main content
Fig. 6 | Infectious Agents and Cancer

Fig. 6

From: Assessing the risk of high-grade squamous intraepithelial lesions (HSIL+) in women with LSIL biopsies: a machine learning-based study

Fig. 6

Evaluation and validation of clinical decision curve of nomogram (A training set, B validation set). The clinical decision curve was constructed to evaluate the clinical practicability of the prediction model. A Clinical decision curve of training set; B Clinical decision curve of the validation set. In the DCA curve, the horizontal coordinate represented the threshold probability and the vertical coordinate represented the net benefit rate. The None line represented that none of the samples were patients with missed HSIL+ and that the clinical net benefit rate was 0 without treatment. The ALL line represented the net benefit rate when all samples were missed patients. The dotted line represented the net benefit rate of patients in this column chart model, and the dotted in the upper right, indicating that the model had good clinical utility

Back to article page